v3.26.3
OPTIONS AND AWARDS (Tables)
 9 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Assumptions for Stock Options Granted
The Company used the following assumptions for stock options granted during the three months ended September 30, 2026 and 2025:
Grant YearOptions GrantedWeighted Average Risk-Free RateExpected LifeWeighted Average VolatilityWeighted Average Dividend Yield
20262024.5%6.2 years29.2%0.1%
20251904.0%6.2 years39.1%0.2%

The Company used the following assumptions for stock options granted during the nine months ended September 30, 2026 and 2025:
Grant YearOptions GrantedWeighted Average Risk-Free RateExpected LifeWeighted Average VolatilityWeighted Average Dividend Yield
20267114.1%6.2 years35.6%0.1%
20255174.1%6.2 years39.3%0.2%
Schedule of Exercise Price and Fair Value Displayed at Grant Date for Stock Option Grants
For the nine months ended September 30, 2026 and 2025, the following represents the exercise price and fair value displayed at grant date for stock option grants:
Grant YearGrantedWeighted Average Exercise PriceWeighted Average Fair Value of Options
2026711$193.74 $81.81 
2025517$149.08 $66.56 
Schedule of Employee Stock Option Roll Forward
The following table represents the employee stock option activity during the nine months ended September 30, 2026:
Number of Options OutstandingWeighted Average
Exercise Price		Number of
Options Vested		Weighted Average Exercise Price of Options Vested
January 1, 20264,071 $96.87 1,991 $67.10 
Granted711 193.74 
Forfeited(58)134.57 
Exercised(335)65.06 
September 30, 20264,389 $114.50 2,100 $76.25 
Schedule of Aggregate Intrinsic Value of Options
The aggregate intrinsic value of options outstanding, vested, expected to vest and exercised as of September 30, 2026 and December 31, 2025 is as follows:
OptionsSeptember 30, 2026December 31, 2025
Outstanding$271,176 $317,984 
Vested201,068 213,189 
Expected to vest67,004 98,487 
Schedule of Nonvested Restricted Stock Awards
A summary of the status of the Company's non-vested restricted stock awards as of September 30, 2026 and changes during the nine months ended September 30, 2026 is presented below:
Non-Vested Restricted AwardsWeighted Average Grant Date Fair Value
Nonvested at January 1, 2026436 $129.54 
Granted248 198.89 
Vested(180)148.61 
Forfeited(11)134.57 
Nonvested at September 30, 2026
493 $157.48 
Schedule of Stock-Based Compensation Expense
Stock-based compensation expense recognized for the Company's equity incentive plans and long-term incentive plan for the three and nine months ended September 30, 2026 and 2025 was as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Stock-based compensation expense related to stock options$10,035 $8,361 $28,143 $22,568 
Stock-based compensation expense related to restricted stock awards5,054 3,999 14,161 11,162 
Stock-based compensation expense related to restricted stock awards to non-employee directors
602 508 1,976 1,457 
Stock-based compensation expense related to performance stock units3,147 — 4,213 — 
TOTAL$18,838 $12,868 $48,493 $35,187